Aspirin and Clopidogrel Resistance
Authors:
- Erin D. MichosEMErin D. Michos
- Reza ArdehaliRAReza Ardehali
- Roger S. BlumenthalRBRoger S. Blumenthal
- Richard A. LangeRLRichard A. Lange
- Hossein ArdehaliHAHossein Ardehali
- 1 April 2006
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 81 (4) , 518-526
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Aspirin resistance: Table 1BMJ, 2004
- Antiplatelet Effect of Aspirin in Patients With Cerebrovascular DiseaseStroke, 2004
- Aspirin ResistanceAnnals of Pharmacotherapy, 2002
- Aspirin in the prophylaxis of coronary artery diseaseCurrent Opinion in Cardiology, 2002
- Aspirin for Primary Prevention of Coronary EventsNew England Journal of Medicine, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- One hundred years of aspirinThe Lancet, 1997
- Acetylation of prostaglandin synthase by aspirin.Proceedings of the National Academy of Sciences, 1975
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975
- Aspirin Selectively Inhibits Prostaglandin Production in Human PlateletsNature New Biology, 1971